DK1024807T3 - Anvendelse af forbindelsen 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamidoacetat for fremstilling af et anti-inflammatorisk medikament med forhindring af gastrisk hypersecernering og forstyrrelse af nyrefunktionen - Google Patents

Anvendelse af forbindelsen 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamidoacetat for fremstilling af et anti-inflammatorisk medikament med forhindring af gastrisk hypersecernering og forstyrrelse af nyrefunktionen

Info

Publication number
DK1024807T3
DK1024807T3 DK97935773T DK97935773T DK1024807T3 DK 1024807 T3 DK1024807 T3 DK 1024807T3 DK 97935773 T DK97935773 T DK 97935773T DK 97935773 T DK97935773 T DK 97935773T DK 1024807 T3 DK1024807 T3 DK 1024807T3
Authority
DK
Denmark
Prior art keywords
methylbenzoyl
methoxyphenyl
methyl
compound
acetamidoacetate
Prior art date
Application number
DK97935773T
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ricerca Srl
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ricerca Srl, Sigma Tau Ind Farmaceuti filed Critical Medosan Ricerca Srl
Application granted granted Critical
Publication of DK1024807T3 publication Critical patent/DK1024807T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97935773T 1997-08-08 1997-08-08 Anvendelse af forbindelsen 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamidoacetat for fremstilling af et anti-inflammatorisk medikament med forhindring af gastrisk hypersecernering og forstyrrelse af nyrefunktionen DK1024807T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1997/000209 WO1999007363A1 (en) 1997-08-08 1997-08-08 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment

Publications (1)

Publication Number Publication Date
DK1024807T3 true DK1024807T3 (da) 2003-08-04

Family

ID=11332729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97935773T DK1024807T3 (da) 1997-08-08 1997-08-08 Anvendelse af forbindelsen 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamidoacetat for fremstilling af et anti-inflammatorisk medikament med forhindring af gastrisk hypersecernering og forstyrrelse af nyrefunktionen

Country Status (6)

Country Link
EP (1) EP1024807B1 (da)
JP (1) JP2001513497A (da)
AT (1) ATE237326T1 (da)
DE (1) DE69721077T2 (da)
DK (1) DK1024807T3 (da)
WO (1) WO1999007363A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297140B1 (it) 1997-12-24 1999-08-03 Sigma Tau Ind Farmaceuti Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
IT1302898B1 (it) * 1998-12-03 2000-10-10 Medosan Ricerca Srl Uso di amtolmetine guacil per la produzione di farmaci ad effettoantiinfiammatorio nelle infiammazioni intestinali.
CA2516618A1 (en) * 2003-02-27 2004-09-10 Shirankai Kyoto University Faculty Of Medicine Alumni Association Inc. Pharmaceutical composition for treatment of drug dependence
CN100390144C (zh) * 2006-03-29 2008-05-28 安徽省庆云医药化工有限公司 1-甲基-5-对甲苯酰吡咯-2-乙酰氨基乙酸愈创木酚酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162856A (en) * 1981-07-20 1984-02-28 Dushan M. Dvornik Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.

Also Published As

Publication number Publication date
ATE237326T1 (de) 2003-05-15
DE69721077D1 (de) 2003-05-22
EP1024807B1 (en) 2003-04-16
WO1999007363A1 (en) 1999-02-18
EP1024807A1 (en) 2000-08-09
JP2001513497A (ja) 2001-09-04
DE69721077T2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
PL350786A1 (en) Cell adhesion−inhibiting antiinflammatory and immune−suppressive compounds
BG105109A (en) Cell adhesion-inhibiting anti-inflammatory compounds
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
DK0457950T3 (da) Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme
CA2218555A1 (en) Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
NO983543L (no) Preparat omfattende interleukin-1-inhibitor og polymer med regulert frigivelse
BG105653A (en) Aromatic heterocyclic compounds as anti-inflammatory agents
IS8255A (is) P38 kínasatálmar staðsettir á 5 hluta heteróhring
NO20006559L (no) Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
IL98033A0 (en) Pharmaceutical compositions including a non-steroidal anti-inflammatory drug and a prostaglandin
ID30225A (id) Tablet matriks yang memungkinkan pelepasan yang diperlama dari gliklazida setelah pemberian secara oral
SE9802793D0 (sv) New compounds
PT1105105E (pt) Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
DE69832695D1 (de) Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
DK1024807T3 (da) Anvendelse af forbindelsen 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamidoacetat for fremstilling af et anti-inflammatorisk medikament med forhindring af gastrisk hypersecernering og forstyrrelse af nyrefunktionen
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
CO5261530A1 (es) Cristales de derivado de acido oxiiminoalcanoico
NO20013015D0 (no) Liposominfluminsyre - ny transdermal antiinflammatorisk medisin
GB9619634D0 (en) Prevention of gastrointestinal damage
IT8819447A0 (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.
SI1024807T1 (en) Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment